Concepedia

M. Nazim Abbas

MN

Statistics

Publications

3

Citations

159

H-Index

3

Active since

2016

Affiliations

The University of Adelaide(Current)

Centre for Cancer Biology

South Australia Pathology

Royal Adelaide Hospital

University of South Australia

M. Nazim Abbas is an author at The University of Adelaide specializing in tumor immunity, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2016–2019

3

Publications

3

Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma

Tessa Gargett, M. Nazim Abbas, Paul Rolan et al. · Cancer Immunology Immunotherapy · 2018 · 108 citations · Full text

, , +7

GM‐CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid‐derived suppressor cells <i>in vitro</i>

Tessa Gargett, Susan N. Christo, Timothy R. Hercus et al. · Clinical & Translational Immunology · 2016 · 34 citations · Full text

Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow up

M. Nazim Abbas, Adeola Oluwakemi Ayoola, Sunita Padman et al. · Journal of Thoracic Disease · 2019 · 17 citations · Full text

1–3 of 3